Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Biophor Diagnostics, Inc. · Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

324 daysmedian FDA review time
447 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K142293Rapidfret Oral Fluid Assay for Methamphetamine, Rapidfret OrBiophor Diagnostics, Inc.2015-09-183960
K142129RAPIDFRET ORAL FLUID ASSAY FOR COCAINE, RAPIDFRET ORAL FLUIDBiophor Diagnostics, Inc.2015-07-243540
K141748RAPIDFRET ORAL FLUID ASSAY FOR AMPHETAMINE, RAPIDFRET ORAL FBiophor Diagnostics, Inc.2015-05-203240
K133047RAPIDFRET ORAL FLUID ASSAY FOR MDMA, RAPIDFRET ORAL FLUID CABiophor Diagnostics, Inc.2014-12-184470
K133642RAPIDFRET ORAL FLUID ASSAY FOR OPIATES; RAPIDFRET ORAL FLUIDBiophor Diagnostics, Inc.2014-01-24580
K132096RAPIDFRET ORAL FLUID ASSAY FOR THC, THC CALIBRATOR SET, THC Biophor Diagnostics, Inc.2013-10-181020
K122703RAPIDFRET ORAL FLUID ASSAY FOR PCP, PCP CALIBRATOR SET, PCP Biophor Diagnostics, Inc.2013-04-252330

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda